The Medical Defense Company™
San Diego based biopharmaceutical company. Developing next-gen treatments for unmet medical needs and biochemical threats.
Private sector companies haven't figured out how to make developing antidotes to biological weapons economically feasible. "We are woefully underprepared today."
-- @JackJFernandes (J.D. '19), @regenicabio#LongLA#UCLAEntrepreneurs https://t.co/IsvkKUD7zN
Regenica is a biopharmaceutical company developing treatments for unmet medical needs and biochemical threats. Its first antidote protects against nerve agent exposure and pesticide poisoning.
#UCLAEntrepreneurs | #LongLA
#CTSSoCal Picture Highlights! Panel Discussion with @pfizer Senior Director, Drug Product Supply Sourcing, Francis Dumont and @RegenicaBio CEO, Jack Fernandes!
#CTSSoCal Please welcome back @RegenicaBio CEO, Jack Fernandes! He’ll be addressing falsified medication legislation in the EU and how it impact comparator sourcing for your trial!
#CTSSoCal The commercialization dilemma – go it alone, partner, or divest via acquisition? Panel includes @pfizer Senior Director of Drug Product Supply Sourcing, Francis Dumont, and @RegenicaBio CEO, Jack Fernandes!
WOW! Our very own @UCLA_Law alumnus @JackJFernandes talks to @Forbes about his startup, @RegenicaBio, explaining that he envisions his company developing advanced measures to counter bio-terrorism with a focus on #prevention & detection. Read more here: https://t.co/smjlYgXRgE
Battling cases of nerves: '18 alum @JackJFernandes & his #sandiego#biotech startup @regenicabio -- which is creating antidotes to nerve agents used in war -- profiled in @Forbes
https://t.co/OO1ZUrVgz2
We are proud to be known as the Medical Defense Company™️. Please check out this article on what we are doing, and learn a bit more about our founder, Jack J. Fernandes.
#SanDiego#medicine#pharmaceuticals#antidotes#biotech
https://t.co/jSoNVtxlve
the value of an idea is ZERO. if you take it to the marketplace it may be worth billions (both in social return and economic return), but its value depends on its EXECUTION. never forget, we investors do not invest in ideas but in the people leading them.